Next week’s stock market catalysts: earnings, Fed Beige Book & jobs report, ex-dividend dates, IPOs, splits, and major events ...

Allogene Therapeutics stock is trying to create CAR-T treatments using cells from healthy donors. Here's what investors need ...

Septerna, Inc. has surged >315% since May 2025, driven by its GPCR-focused drug discovery and a high-profile collaboration ...

Union Pacific Corporation: strong Q2 revenue growth but Norfolk Southern merger uncertainty and fair valuation limit upside.

Gold outlook for H2: breakout + seasonality signal a rally, with liquidity gap targets up to $5,400/oz. Click for more ...

PayPal tops Nasdaq weekly decliners as deal talks fall off; CrowdStrike leads gainers after stellar results The Nasdaq ...

What was the biggest takeaway from Federal Reserve Chairman Kevin Warsh's speech at the Jackson Hole Economic Policy ...

PMT preferred shares (PMT-A/PMT-B) face LIBOR transition litigation; the Ninth Circuit leaves key issues for the district ...

Park Hotels & Resorts remains a Buy, with valuation still reflecting a significant discount despite strong operating results.

OKE demonstrated strong Q2 2026 results, with adjusted EBITDA rising by 7% YoY to $2.1 billion and EPS per share rising by 13 ...

MasTec is rated as a Strong Buy due to a record $21.4B backlog, strong Q2 growth, and a rising EPS outlook supporting a $337 ...

Fox Corporation grows aggressive via Roku and possible News Corporation reunion; explore merger hurdles and synergy questions ...